Clinical Trials Directory

Trials / Unknown

UnknownNCT06374953

A Novel Viscoelastic Test Based on Ultrasonic Guided Wave for Identifying Hyperfibrinolysis Rapidly

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares the results of the existing fibrinolysis monitoring technology to the Ultrasound-based viscoelastic hemostasis analysis, a new method, using small amount of extra blood obtained during routine blood draws in surgery patients.

Detailed description

Ultrasound-based viscoelastic hemostasis analysis is a novel POC diagnostic method, which is suitable for operating theatres and emergency rooms. The novel viscoelastic hemostasis analysis uses ultrasound guided waves to characterize the dynamic changes in viscoelastic properties of a blood sample during coagulation and clot lysis, which will be an assay of hyperfibrinolysis for critically ill patients. This single-center, prospective, observational pilot study will evaluate the analytical performance as well as compared to conventional viscoelastic testing methods.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasound-based viscoelastic hemostasis analysisAdding recombinant tissue plasminogen activator (rtPA) and/or Tranexamic acid (TXA)to blood in vitro, and fibrinolysis capacity is assessed using ultrasound-guided viscoelastic coagulation testing.

Timeline

Start date
2024-03-26
Primary completion
2024-09-30
Completion
2024-09-30
First posted
2024-04-19
Last updated
2024-06-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06374953. Inclusion in this directory is not an endorsement.